| Quarterly Financials | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
Revenue  | 52 | 62 | 81 | 111 | 109 | 127 | 109 | 99 | 90 | 92 | 122 | 125 | 115 | 97 | 85 | 103 | 107 | 84 | 86 | 109 | 118 |
| Expenses | 41 | 54 | 56 | 84 | 81 | 88 | 81 | 77 | 73 | 79 | 103 | 112 | 93 | 76 | 73 | 83 | 93 | 78 | 79 | 99 | 100 |
| EBITDA | 11 | 8 | 25 | 27 | 28 | 39 | 29 | 22 | 17 | 13 | 19 | 14 | 22 | 21 | 12 | 20 | 14 | 6 | 7 | 10 | 19 |
| Operating Profit % | 20 % | 11 % | 31 % | 23 % | 24 % | 29 % | 23 % | 22 % | 17 % | 12 % | 15 % | 10 % | 19 % | 21 % | 13 % | 16 % | 12 % | 7 % | 8 % | 8 % | 15 % |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 6 | 7 | 7 | 6 | 7 | 7 | 7 | 7 | 9 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 8 | 6 | 23 | 24 | 24 | 35 | 26 | 19 | 14 | 9 | 14 | 8 | 13 | 11 | 5 | 14 | 7 | -1 | -0 | 2 | 9 |
| Tax | 2 | 2 | 2 | 3 | 1 | 3 | 3 | 2 | 4 | 2 | 3 | -9 | 4 | 3 | 2 | 4 | 2 | -0 | -0 | 1 | 3 |
| Net Profit | 7 | 4 | 21 | 21 | 23 | 32 | 23 | 18 | 10 | 7 | 12 | 17 | 10 | 8 | 4 | 10 | 5 | -1 | 0 | 1 | 7 |
| EPS in ₹ | 3.34 | 1.77 | 10.39 | 10.51 | 11.52 | 15.02 | 10.29 | 7.90 | 4.42 | 3.21 | 5.24 | 7.65 | 4.29 | 3.43 | 1.48 | 4.11 | 2.23 | -0.29 | 0.06 | 0.44 | 2.84 |
Tatva Chintan Pharma
Tatva Chintan Pharma
1,145.75
+130.30
(12.83%)
Q1 Quarterly Results are out. Check out the updated financials17 hours ago
Show All
Market Cap
2,375.30 Cr
EPS
2.44
PE Ratio
332.22
Dividend Yield
0.10 %
Industry
Chemicals52 Week High
1,102.00
52 Week Low
621.00
PB Ratio
3.22
Debt to Equity
0.15
Sector
Specialty Chemicals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from5 analysts
Company News
View All News
Tatva Chintan Pharma Shares Surge 20% Following Strong Quarterly Results and New Investor Interest
1 day ago
1 day agoTatva Chintan Pharma Chem Ltd. shares jumped nearly 20% to reach a 52-week high of ₹1,218.5 following strong quarterly performance. The company reported a 27.7% increase in profit after tax to ₹6.7 crore, while revenue grew 10.8% to ₹117 crore. EBITDA expanded 37.4% to ₹17 crore, with operating margins improving to 14.8% from 12% in the previous year. The stock also gained momentum after Mukul Agrawal acquired a 1.28% stake in the company. Promoters hold 72% of the company at the end of the June quarter. The stock has gained 27% in the past month and 39.11% year-to-date.
Tatva Chintan is experiencing strong growth supported by its leadership in green chemistry, expanded manufacturing capacity, and increasing global demand for specialty chemicals. The company operates across three key segments: PTC (Phase Transfer Catalysts), SDA (Structural Directing Agents), and battery materials, all of which are benefiting from rising international demand for niche specialty chemicals.
Tatva Chintan Reports Q1 FY2026 Results, Approves Director Reappointments and CFO Resignation2 days ago
2 days agoTatva Chintan Pharma Chem Limited announced its unaudited financial results for the quarter ended June 30, 2025. The company reported consolidated revenue from operations of Rs 1,168.64 million and net profit of Rs 57.13 million for the quarter. The board approved reappointments of three key directors - Managing Director Chintan Nitinkumar Shah, and Whole-time Directors Ajaykumar Mansukhlal Patel and Shekhar Rasiklal Somani - for one-year terms from February 1, 2026 to January 31, 2027. Additionally, three Independent Directors - Subhash Ambubhai Patel, Manher Chimanlal Desai, and Avani Rajesh Umatt - were reappointed for five-year terms from February 27, 2026 to February 26, 2031. All reappointments are subject to shareholder approval at the upcoming Annual General Meeting. The company also announced the resignation of Chief Financial Officer Ashok Bothra, effective August 30, 2025, citing personal and professional goals as reasons for his departure.
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
2,889.60 | #1 1,47,910.00 | 70.62 | 13,387.50 | 5.69 | #1 2,096 | 40.49 | 32.04 | |
3,040.80 | 93,385.70 | 65.14 | 14,825.80 | 12.13 | 1,251 | 71.41 | 39.05 | |
3,508.90 | 39,285.70 | 71.82 | 4,737.00 | -25.09 | 523 | #1 89.11 | 47.36 | |
1,902.60 | 26,225.70 | #1 37.60 | 8,281.93 | -3.26 | 724 | -20.24 | 36.75 | |
498.35 | 25,334.50 | 41.23 | 4,664.30 | 10.33 | 555 | 46.09 | 50.59 | |
5,003.40 | 25,171.50 | 90.03 | 2,393.10 | 0.37 | 289 | 34.94 | 56.98 | |
5,045.00 | 22,300.80 | 48.73 | #1 15,339.40 | - | 479 | -83.27 | 48.40 | |
1,868.80 | 19,700.60 | 48.64 | 2,248.17 | -8.77 | 424 | 18.04 | 39.85 | |
6,667.00 | 19,430.10 | 38.90 | 5,692.40 | #1 18.99 | 499 | 18.11 | 33.60 | |
5,194.50 | 16,513.50 | 40.17 | 2,269.15 | -28.91 | 409 | -15.27 | 53.37 |
Forecast
Actual
Growth Rate
Revenue Growth
-6.61 %
Net Income Growth
-33.19 %
Cash Flow Change
252.92 %
ROE
-53.39 %
ROCE
-33.66 %
EBITDA Margin (Avg.)
22.20 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 144 | 188 | 249 | 315 | 658 | 759 | 819 | 836 |
| Fixed Assets | 57 | 67 | 111 | 120 | 160 | 196 | 427 | 553 |
| Current Assets | 77 | 114 | 133 | 184 | 436 | 312 | 298 | 265 |
| Capital Work in Progress | 10 | 6 | 5 | 10 | 52 | 231 | 77 | 22 |
| Investments | 1 | 0 | 0 | 0 | 0 | 0 | 10 | 134 |
| Other Assets | 76 | 115 | 133 | 185 | 447 | 332 | 305 | 0 |
| Total Liabilities | 144 | 188 | 249 | 315 | 658 | 759 | 819 | 836 |
| Current Liabilities | 63 | 73 | 88 | 118 | 171 | 239 | 80 | 96 |
| Non Current Liabilities | 22 | 35 | 44 | 31 | 14 | 5 | 2 | 1 |
| Total Equity | 59 | 80 | 118 | 166 | 473 | 515 | 737 | 739 |
| Reserve & Surplus | 51 | 72 | 110 | 146 | 451 | 493 | 714 | 715 |
| Share Capital | 8 | 8 | 8 | 20 | 22 | 22 | 23 | 23 |
Cash Flow
| Cash Flow | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | -10 | 8 | -5 | -6 | 59 | -36 | 8 |
| Investing Activities | -30 | -17 | -40 | -21 | -197 | -101 | -121 |
| Operating Activities | 13 | 7 | 25 | 20 | 20 | 28 | 98 |
| Financing Activities | 7 | 17 | 10 | -5 | 235 | 38 | 31 |
Share Holding
| % Holding | Jul 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Aug 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
| Promoter | 79.17 % | 79.17 % | 79.17 % | 79.17 % | 79.17 % | 79.17 % | 79.17 % | 79.17 % | 79.17 % | 75.02 % | 72.02 % | 72.02 % | 72.02 % | 72.02 % | 72.02 % | 72.02 % | 72.02 % | 72.02 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 4.41 % | 4.21 % | 3.65 % | 3.37 % | 3.33 % | 3.36 % | 3.30 % | 3.26 % |
| DIIs | 5.52 % | 7.36 % | 7.78 % | 7.95 % | 10.56 % | 11.16 % | 11.52 % | 11.71 % | 11.07 % | 13.68 % | 13.79 % | 13.06 % | 12.84 % | 10.63 % | 6.82 % | 6.34 % | 5.46 % | 5.11 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 9.89 % | 6.44 % | 6.62 % | 6.35 % | 6.03 % | 5.49 % | 5.01 % | 5.09 % | 5.91 % | 6.23 % | 8.72 % | 9.38 % | 10.49 % | 12.44 % | 15.95 % | 16.33 % | 16.92 % | 17.47 % |
| Others | 5.42 % | 7.03 % | 6.43 % | 6.53 % | 4.24 % | 4.19 % | 4.31 % | 4.03 % | 3.85 % | 5.07 % | 1.06 % | 1.33 % | 1.00 % | 1.54 % | 1.87 % | 1.95 % | 2.30 % | 2.14 % |
| No of Share Holders | 11 | 89,438 | 88,311 | 89,930 | 84,358 | 76,267 | 71,958 | 70,037 | 70,799 | 71,340 | 74,628 | 74,519 | 73,730 | 73,912 | 79,623 | 79,009 | 78,393 | 76,792 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5 | 2 | 2 | 2 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.22 | 0.12 | 0.19 | 0.3 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 24 Jul 2025 |  Quarterly Result Announcement | NA | 24 Jul 2025 | 944.95 | 997.40 |
| 02 May 2025 | Quarterly Result Announcement | NA | 02 May 2025 | 761.40 | 706.00 |
| 28 Jan 2025 | Quarterly Result Announcement | NA | 28 Jan 2025 | 843.90 | 814.75 |
| 25 Oct 2024 | Quarterly Result Announcement | NA | 25 Oct 2024 | 1,002.00 | 949.30 |
| 20 Sept 2024 |  Annual General Meeting | NA | 20 Sept 2024 | 1,000.80 | 972.05 |
| 07 Sept 2024 |  Dividend | ₹ 2.00 /share | 06 Sept 2024 | 1,228.15 | 972.95 |
| 08 Sept 2023 | Dividend | ₹ 2.00 /share | 08 Sept 2023 | 1,835.95 | 1,636.45 |
| 09 Sept 2022 | Dividend | ₹ 2.00 /share | 08 Sept 2022 | 2,478.80 | 2,480.20 |
Announcements
Announcement under Regulation 30 (LODR)-Newspaper Publication1 day ago
1 day agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome1 day ago
1 day agoAnnouncement under Regulation 30 (LODR)-Investor Presentation2 days ago
2 days agoAnnouncement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)2 days ago
2 days agoAnnouncement under Regulation 30 (LODR)-Change in Directorate2 days ago
2 days agoBoard Meeting Outcome for Outcome Of The Board Meeting Held On 24.07.20252 days ago
2 days agoUnaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended 30 June 20252 days ago
2 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation8 days ago
8 days agoBoard Meeting Intimation for Intimation Of Board Meeting To Be Held On Thursday 24.07.20258 days ago
8 days agoDisclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jul 07, 2025
Jul 07, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 05, 2025
Jul 05, 2025Closure of Trading WindowJun 25, 2025
Jun 25, 2025Announcement under Regulation 30 (LODR)-Credit RatingJun 17, 2025
Jun 17, 2025Clarification On Price MovementMay 23, 2025
May 23, 2025Clarification sought from Tatva Chintan Pharma Chem LtdMay 22, 2025
May 22, 2025Clarification On Increase / Spurt In VolumeMay 21, 2025
May 21, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 14, 2025
May 14, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 09, 2025
May 09, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 05, 2025
May 05, 2025Announcement under Regulation 30 (LODR)-Investor PresentationMay 05, 2025
May 05, 2025Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderMay 05, 2025
May 05, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 03, 2025
May 03, 2025Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Financial Year Ended On 31 March 2025May 02, 2025
May 02, 2025Appointment Of Secretarial Auditor Cost Auditor And Internal AuditorMay 02, 2025
May 02, 2025Announcement under Regulation 30 (LODR)-Dividend UpdatesMay 02, 2025
May 02, 2025Corporate Action-Board approves DividendMay 02, 2025
May 02, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On 02.05.2025May 02, 2025
May 02, 2025Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2Apr 29, 2025
Apr 29, 2025Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 29, 2025
Apr 29, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 28, 2025
Apr 28, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 25, 2025
Apr 25, 2025Board Meeting Intimation for Board Meeting Intimation For Intimation Of Board Meeting To Be Held On Friday 02.05.2025Apr 25, 2025
Apr 25, 2025Intimation Of Change In Contact Details Of MUFG Intime India Private Limited Registrar And Share Transfer Agent (RTA) Of The Company.Apr 19, 2025
Apr 19, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 03, 2025
Apr 03, 2025Closure of Trading WindowMar 26, 2025
Mar 26, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 24, 2025
Mar 24, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 18, 2025
Mar 18, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJan 31, 2025
Jan 31, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 29, 2025
Jan 29, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJan 28, 2025
Jan 28, 2025Integrated Filing (Financial)Jan 28, 2025
Jan 28, 2025Announcement under Regulation 30 (LODR)-Investor PresentationJan 28, 2025
Jan 28, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On 28.01.2025Jan 28, 2025
Jan 28, 2025Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Nine Months Ended On 31 December 2024Jan 28, 2025
Jan 28, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 17, 2025
Jan 17, 2025Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Tuesday 28.01.2025Jan 17, 2025
Jan 17, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2025
Jan 06, 2025Intimation For Change Of Name Of Registrar And Share Transfer Agent (RTA) Of The Company.Jan 01, 2025
Jan 01, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 04, 2024
Dec 04, 2024Announcement under Regulation 30 (LODR)-Credit RatingNov 06, 2024
Nov 06, 2024Technical Indicators
RSI(14)
Neutral 73.71
ATR(14)
Volatile 53.01
STOCH(9,6)
Neutral 67.33
STOCH RSI(14)
Neutral 71.50
MACD(12,26)
Bullish 11.68
ADX(14)
Strong Trend 30.86
UO(9)
Bearish 51.34
ROC(12)
Uptrend And Accelerating 19.79
WillR(14)
Neutral -24.35
Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 ICICI Prudential Smallcap Fund Direct Plan-Growth | 0.22% | -39457 | -0.04% | -0.02% | |
 Nippon India ELSS Tax Saver Fund Direct-Growth | 0.47% | -4910 | 0.01% | 0.10% | |
| ICICI Prudential Commodities Fund Direct - Growth | 0.19% | 0 | 0.00% | 0.03% | |
| ICICI Prudential MNC Fund Direct - Growth | 0.95% | 0 | 0.05% | 0.22% | |
| Nippon India Small Cap Fund Direct- Growth | 0.00% | 0 | 0.00% | 0.00% | |
 SBI Mid Cap Direct Plan-Growth | 0.00% | 0 | 0.00% | 0.00% |
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
